We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

144 hedge funds and large institutions have $1.61B invested in IDEAYA Biosciences in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 63 increasing their positions, 41 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 41

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

21% more capital invested

Capital invested by funds: $1.33B → $1.61B (+$281M)

4.95% more ownership

Funds ownership: 98.79% → 103.73% (+4.9%)

4% more funds holding

Funds holding: 138 → 144 (+6)

13% less call options, than puts

Call options by funds: $698K | Put options by funds: $804K

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
144
Holders Change
+6
Holders Change %
+4.35%
% of All Funds
2.29%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
18
Increased
63
Reduced
41
Closed
12
Calls
$698K
Puts
$804K
Net Calls
-$106K
Net Calls Change
+$4.97M

Top Buyers

Rank Fund Capital Flow
1
Holocene Advisors
Holocene Advisors
New York
+$26.2M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$16.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.4M
4
LGM
Logos Global Management
California
+$12.7M
5
DCM
Driehaus Capital Management
Illinois
+$11M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$21.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.4M
3
BI
BVF Inc
California
-$10.1M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.31M
5
IC
Ikarian Capital
Texas
-$6.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Manhattan
26
First Manhattan
New York
$16M – – –
BCM
27
Boone Capital Management
Georgia
$15.4M +$1.88M +74,249 +15%
Northern Trust
28
Northern Trust
Illinois
$15.1M +$491K +19,380 +4%
N
29
Nuveen
North Carolina
$14.7M -$538K -21,228 -4%
DCM
30
DAFNA Capital Management
California
$13.5M +$507K +20,000 +4%
Charles Schwab
31
Charles Schwab
California
$11.8M +$7.39M +291,240 +199%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$11.8M +$5.66M +223,143 +105%
CS
33
Candriam SCA
Luxembourg
$11.6M +$507K +19,999 +5%
Goldman Sachs
34
Goldman Sachs
New York
$11.3M +$759K +29,943 +8%
Ensign Peak Advisors
35
Ensign Peak Advisors
Utah
$9.81M +$3.31M +130,350 +56%
Axa
36
Axa
France
$9.27M -$30.6K -1,206 -0.3%
EAM
37
Eventide Asset Management
Massachusetts
$9.04M +$8.5M +335,000 New
OM
38
Opaleye Management
Massachusetts
$8.4M -$2.62M -103,500 -25%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$7.85M +$174K +6,849 +2%
Invesco
40
Invesco
Georgia
$7.83M +$1.55M +61,157 +27%
Ameriprise
41
Ameriprise
Minnesota
$7.38M +$794K +31,312 +13%
UBS AM
42
UBS AM
Illinois
$7.3M +$6.86M +270,391 New
WP
43
Woodline Partners
California
$6.49M +$1.61M +63,404 +36%
Morgan Stanley
44
Morgan Stanley
New York
$6.28M -$3.04M -119,790 -34%
IC
45
Ikarian Capital
Texas
$5.85M -$6.95M -273,944 -56%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$5.3M +$561K +22,121 +13%
NCM
47
Nantahala Capital Management
Connecticut
$3.94M – – –
Two Sigma Advisers
48
Two Sigma Advisers
New York
$3.69M -$2.21M -87,200 -39%
PHP
49
Parkman Healthcare Partners
Connecticut
$3.58M +$136K +5,362 +4%
Rafferty Asset Management
50
Rafferty Asset Management
New York
$3.48M +$103K +4,059 +3%
1
2
3 4 5

IDYA Hedge Fund Activity: Q3 2023 in Review

144 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2023, worth a combined $1.61B — up 21% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IDYA positions and 12 closed out — a net gain of 6 holders — while 63 added to existing stakes and 41 trimmed.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $26.2M. The largest seller was Avidity Partners Management, cutting an estimated $21.3M.

  • 144 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2023, up from 138 in Q2 2023.
  • Funds reported $1.61B of IDEAYA Biosciences stock for Q3 2023, up 21% quarter-over-quarter.
  • 18 funds opened new IDEAYA Biosciences positions in Q3 2023 and 12 closed out, a net change of +6 holders.
  • The largest IDEAYA Biosciences buyer in Q3 2023 was Holocene Advisors, an estimated $26.2M added.
  • The largest IDEAYA Biosciences seller in Q3 2023 was Avidity Partners Management, an estimated $21.3M sold.

Based on aggregated 13F filings for Q3 2023.